We hypothesize that the novel finding of decreased sphingosine in vitamin E responders reflects decreased TNF-α activity in responders and hope that these findings will provide impetus to future studies of the sphingosine-ceramide pathway in NASH. This evidence concerns the gene TNF and metabolic dysfunction-associated steatohepatitis.